Expanded Access for LJPC-501

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The primary objective of the study is to provide access to LJPC-501 for distributive shock patients who remain hypotensive despite receiving fluid and vasopressor therapy.
Epistemonikos ID: 5fd04c75194e03f8f612c3bf3a2c44c3ed354583
First added on: May 21, 2024